Cash Flow Statement
Growth Metrics

Opko Health (OPK) Operating Leases (2019 - 2026)

Opko Health filings provide 8 years of Operating Leases readings, the most recent being $35.6 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 26.12% to $35.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $35.6 million, a 26.12% decrease, with the full-year FY2025 number at $36.8 million, down 24.64% from a year prior.
  • Operating Leases hit $35.6 million in Q1 2026 for Opko Health, down from $36.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $64.8 million in Q3 2024 to a low of $26.5 million in Q1 2023.
  • Median Operating Leases over the past 5 years was $37.3 million (2025), compared with a mean of $42.7 million.
  • The widest YoY moves for Operating Leases: up 93.61% in 2023, down 51.18% in 2023.
  • Opko Health's Operating Leases stood at $28.0 million in 2022, then surged by 93.61% to $54.1 million in 2023, then dropped by 9.77% to $48.8 million in 2024, then fell by 24.64% to $36.8 million in 2025, then dropped by 3.2% to $35.6 million in 2026.
  • The last three reported values for Operating Leases were $35.6 million (Q1 2026), $36.8 million (Q4 2025), and $36.3 million (Q3 2025) per Business Quant data.